From 2004 to 2005 in our hospital clinical surveillance of antimicrobial resistance commonly.docVIP
- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
From 2004 to 2005 in our hospital clinical surveillance of antimicrobial resistance commonly
PAGE \* MERGEFORMAT 20
From 2004 to 2005 in our hospital clinical surveillance of antimicrobial resistance commonly
Authors: Zhuo Chao Wen-Xiang Huang Zheng-line Chongzhi Xia Du Yu-ping-ping
【Abstract】 Objective To investigate the surveillance of antimicrobial resistance in China to help group (CHINET) Working Group in Chongqing in November 2004 ~ November 2005 on a variety of common clinical bacterial antimicrobial resistance status quo. Method of drug susceptibility testing using disc diffusion method, drug resistance data analysis software used WHONET5. The results of a year for the first time in our hospital were collected from patients with isolates 1380; Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii, coagulase-negative staphylococcus, Staphylococcus aureus, Enterobacter Enterobacter, and Enterococcus faecalis were the most common bacteria, the respective proportions of 18.6%, 13.6%, 11.3%, 10.0%, 9.4%, 9.1%, 8.0% and 3.9%. Enterobacteriaceae resistant to imipenem and meropenem for the lowest rate, producing extended spectrum β lactamases (ESBLs) in Escherichia coli and Klebsiella pneumoniae strains detection rates were 37.5% and 31.4%; all strains produced ESBLs were sensitive to imipenem and meropenem, Pseudomonas aeruginosa to imipenem and meropenem resistance rates were 37.2% and 39.4%, to ceftazidime resistance rate of 48.9% , and the emergence of pan-resistance to all drug-resistant strains. Acinetobacter baumannii to imipenem and meropenem sensitive rates were 98.6% and 92.8% to cefoperazone / sulbactam sensitivity rate, intermediate rate, resistance rates were 34.8%, 27.5%, 37.7 %. Drug combination analysis showed that pairs of cefoperazone / sulbactam is not sensitive to strain has 58 for the same resistance patterns, PFGE analysis, these strains mainly from two clone. In addition to carbapenem-sensitive, the other drugs are resistant, of which 46 come from the same ward. Conclusion hospit
您可能关注的文档
- Fracture patients with γ-glutamyl transferase and significance of the changes.doc
- Fragile terminals thermal underwear biggest weakness.doc
- Fragile X mental retardation gene FMR1 in the Study of unstable DNA sequences.doc
- Fractures Comparison of different treatment methods_0.doc
- Fractures in the surgical care of patients this procedure care of the safety position.doc
- Fractures Comparison of different treatment methods.doc
- Fragile X syndrome on prenatal screening and diagnosis.doc
- France 'business Infantry' - Arnaud Lagardere.doc
- Fragile X mental retardation protein structure and function of Progress.doc
- Fractures around the knee of the clinical management of complications.doc
- From 400 to 1300 million with scale to create effective - Internet companies keen on TV advertising considerations behind.doc
- From 30000000-1 million old brand Huang interpret the rapid rise of noise Pills.doc
- From a design point of view- Hammer Technology Why not make selling phone-.doc
- From a consumer psychology to see how well the APP mobile Internet era of marketing.doc
- From a gender age said emotional marketing.doc
- From a market follower to a leader in transition.doc
- From a marketing point of view of Xiamen old brand to maintain and enhance.doc
- From a different perspective new product market losses.doc
- From a marketing success stories to talk about off-season ideas.doc
- From a medical ethics in terms of specification of organ transplants.doc
文档评论(0)